“Clinical Impact of Two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer”. Farmeconomia. Health Economics and Therapeutic Pathways 21, no. 1 (February 6, 2020). Accessed December 28, 2025. https://journals.seedstm.com/index.php/FE/article/view/1450.